Compound | Proposed method | Comparison method | |||||||
---|---|---|---|---|---|---|---|---|---|
At 333Â nm | At 485Â nm | ||||||||
Amount taken (μg/ml) | Amount found (μg/ml) | %Found* | Amount taken (μg/ml) | Amount found (μg/ml) | %Found* | Amount taken (μg/ml) | Amount found (μg/ml) | %Found* | |
Rivaroxaban | 0.5 | 0.49 | 98.00 | 1 | 0.99 | 99.00 | 5 | 5.01 | 100.20 |
 | 1 | 0.99 | 99.00 | 3 | 2.97 | 99.00 | 7 | 6.91 | 98.71 |
3 | 3.04 | 101.33 | 5 | 5.08 | 101.60 | 10 | 10.10 | 101.00 | |
5 | 4.97 | 99.40 | 7 | 7.00 | 100.00 | 15 | 14.96 | 99.73 | |
7 | 7.06 | 100.86 | 9 | 8.96 | 99.56 | Â | |||
9 | 8.91 | 99.00 | Â | ||||||
10 | 10.05 | 100.50 | |||||||
X− ± SD |  | 99.72 ± 1.20 |  | 99.83 ± 1.07 |  | 99.91 ± 0.96 | |||
Student's t test | 0.29 (2.26) ** | 0.11(2.36) ** | Â | ||||||
Variance ratio (F test) | 1.56(8.94) ** | 1.23(9.12) ** | |||||||
Edoxaban | 0.5 | 0.50 | 100 | 0.7 | 0.69 | 98.57 | 4 | 4.03 | 100.75 |
1 | 0.99 | 99 | |||||||
 | 1 | 1.000 | 100.00 | 2 | 2.00 | 100.00 | 6 | 5.99 | 99.83 |
3 | 2.99 | 99.67 | 3 | 3.01 | 100.33 | 10 | 10.06 | 100.60 | |
5 | 4.98 | 99.60 | 5 | 5.00 | 100.00 | Â | |||
7 | 7.07 | 101.00 | 7 | 6.98 | 99.71 | ||||
9 | 8.90 | 98.88 | Â | ||||||
10 | 10.05 | 100.50 | |||||||
X− ± SD |  | 99.95 ± 0.68 |  | 99.60 ± 0.68 |  | 100.39 ± 0.49 | |||
Student's t test | 1.11(2.26) ** | 1.23(2.45) ** | Â | ||||||
Variance ratio (F test) | 1.91(19.33) ** | 1.91(19.25) ** |